Effect of melatonin on normal and sclerodermic skin fibroblast proliferation

Clinical and Experimental Rheumatology

Volumn 14, Issue 5, 1996, Pages 493-498

  Carossino, M ^a   Lombardi, A ^a   Matucci Cerinic, M ^b   Pignone, A ^a   Cagnoni, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

fibroblasts; melatonin; proliferation; sclerodermic skin

Indexed keywords

MELATONIN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SCLERODERMA; SKIN FIBROBLAST;

CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; MELATONIN; SCLERODERMA, SYSTEMIC; SKIN; THYMIDINE;

EID: 10144243998     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BANERJEE S, MARGULIS L: Mitotic arrest by melatonin. Exp Cell Res 1973; 78: 314-8.
2. SMYTHE GA, STUART MC, LAZARUS L: Stimulation and suppression of somatomedin activity by serotonin and melatonin. Experientia 1974; 30: 1356-8.
3. MAESTRONI GJM, CONTI A, PIERPAOLI W: Melatonin regulates immunity via an opiatergic mechanism. Clin Neuropharmacol 1986; 9 (suppl. 4): 479-81.
4. MAESTRONI GJM, CONTI A, PIERPAOLI W: Role of the pineal gland in immunity: II melatonin enhances the antibody response via an opiatergic mechanism. Clin Exp Immunol 1987; 68: 384-91.
5. MAESTRONI GJM; CONTI A, PIERPAOLI W: Role of the pineal gland in immunity. Orcadian synthesis and release by melatonin modulates the antibody response and antagonizes the immunosuppressive effect in corticosterone. J Neuroimmun 1986; 13: 19-26.
6. MAESTRONI GJM, CONTI A, PIERPAOLI W: The immunoregulatory role of melatonin. In: GUPTA D, ATTANASIO A, REITER RJ (Eds.): The Pineal Gland and Cancer, Tubingen, Brain Research Promotion, 1988: 33-143.
7. LAPIN V, EBELS I: The role of the pineal gland in the neuroendocrine control mechanism of neoplastic growth. J Neurol Transm 1981; 50: 275-82.
8. NERI B, BROCCHI A, CAROSSINO AM, CINI-NERI G, GEMELLI MT, TOMMASI MS, CAGNONI M: Effects of melatonin administration on cytokine production in patients with advanced solid tumors. Oncology Reports 1994; 1: 1-3.
9. FITZGERALD TJ, VEAL A: Melatonin antagonizes colchicine-induced mitotic arrest. Experientia 1976; 32: 372-3.
10. POFFENHARGER M, FULLER GM: Is melatonin a microtubule inhibitor ? Exp Cell Res 1976; 103: 135-41.
11. BLASK DE: The pineal: an oncostatic gland? In: REITER RJ (Ed.): The Pineal Gland, New York, Raven Press, 1984: 253-84.
12. BLASK DE, PELLETIER DB, HILL SM, LEMUS-WILSON A, GROSSO DS, WILSON ST, WISE ME: Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenesis mechanisms in vivo. J Cancer Res Clin Oncol 1991; 117: 526-32.
13. BLASK DE, HILL SM: Melatonin and cancer: basic and clinical aspect. In: MILES A, PHILBRICK DRS, THOMPSON C (Eds.): Melatonin. Clinical Perspectives, New York, Oxford University Press, 1988: 128-73.
14. REITER RJ: Pineal gland, cellular proliferation and neoplastic growth: an historical account. In: GUPTA D, ATTANASIO A, REITER RJ (Eds.): The Pineal Gland and Cancer, Tubingen, Brain Research Promotion, 1988: 221-32.
15. BLASK DE: Melatonin in oncology. In: YU HS, REITER RJ (Eds): Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications. 1993: 447-75.
16. BOUCEK RJ, ALVAREZ TR: 5-Hydroxytryptamine: a cytospecific growth stimulator of cultured fibroblasts. Science 1970; 167: 898-9.
17. HILL SM, BLASK DE: Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48: 6121-6.
18. BOTSEIN GR, SHERER GK, LEROY EC: Fibroblast selection in scleroderma. An alternative model of fibrosis. Arthritis Rheum 1982; 25: 189-95.
19. FELDMAN SR, TROJANOWSKA M, SMITH EA, LEROY EC: Differential responses of the human papillary and reticular fibroblasts to growth factors. Am J Med Sci 1993; 305: 203-7.
20. WHITESIDE TL, BUCKINGHAM RB, PRINCE RK, RODNAN GP: Products of activated mononuclear cells modulate the accumulation of collagen by normal dermal and scleroderma fibroblasts in culture. J Lab Clin Med 1984, 104: 355-70.
21. WORRALL JG, WHITESIDE TL, PRINCE RK, BUCKINGHAM RB, STACHURA I, RODNAN GP: Persistence of sclerodermalike phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells. Arthritis Rheum 1986; 29: 54-64.
22. PERLISH JS, TIMPL R, FLEISCHMAJER R: Collagen synthesis regulation by the aminopropeptide of procollagen I in normal and scleroderma fibroblasts. Arthritis Rheum 1985; 28: 647-51.